Notes | Year ended | Year ended | ||
30 June | 30 June | |||
2024 | 2023 | |||
(restated) | ||||
£ | £ | |||
Revenue | ||||
Gross profit | ||||
Administrative expenses | 3 | |||
Other operating income | ||||
Operating Profit | ||||
Profit before taxation | ||||
Income tax expense | 5 | |||
Profit for the year | ||||
Total comprehensive profit for the year | ||||
Earnings per share attributable to equity shareholders of the Company | 6 | |||
- | Basic earnings per share | |||
- | Diluted earnings per share |
30 June | 30 June | ||
2024 | 2023 | ||
(restated) | |||
£ | £ | ||
Assets | |||
Non-current assets | |||
Intangible assets | 7 | ||
Total non-current assets | |||
Current assets | |||
Trade and other receivables | 9 | ||
Cash and cash equivalents | 10 | ||
Total assets | |||
Equity | |||
Share capital | 11 | ||
Share premium | 12 | ||
Accumulated losses | 12 | ( | ( |
( | ( | ||
Liabilities | |||
Current liabilities | |||
Trade and other payables | 13 | ||
Loans and borrowings | 14 | ||
Total liabilities | |||
Total equity and liabilities |
Share | Share | Accumulated | Total | |
capital | premium | losses | Equity | |
£ | £ | £ | £ | |
Balance at 30 June 2022 | ( | ( | ||
Profit for the period | ||||
Total comprehensive profit for the period | ||||
Transactions with owners: | ||||
Issue of shares | ||||
Total contribution by and distribution to owners | ||||
Balance at 30 June 2023 as previously presented | ( | ( | ||
Prior period adjustment (note 16) | ( | ( | ||
Balance at 30 June 2023 as restated | ( | ( | ||
Profit for the year | ||||
Total comprehensive profit for the year | ||||
Transactions with owners: | ||||
Issue of shares | ||||
Total contribution by and distribution to owners | ||||
Balance at 30 June 2024 | ( | ( |
Year ended | Year ended | ||
30 June | 30 June | ||
202 4 | 2023 | ||
(restated) | |||
£ | £ | ||
Cash flows from operating activities | |||
Total comprehensive profit for the year | |||
Costs relating to EHGOSF facility | |||
Net write back of trade creditors | ( | ( | |
Net write back of loan notes | ( | ||
( | ( | ||
Increase in trade and other receivables | 9 | ( | |
(Increase)/decrease in trade and other payables | 13 | ( | |
Net cash used in operating activities | ( | ( | |
Cash flows from financing activities | |||
Cash flows from issue for promissory notes | 14 | ||
Cash flows from issue of convertible loan notes | 14 | ||
Net cash flows from financing activities | |||
Net increase in cash and cash equivalents | |||
Cash and cash equivalents at beginning of year | |||
Cash and cash equivalents at year end | 10 |